Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

Clinical trial NCT07564141 · RECRUITING

Trial details

NCT number: NCT07564141
Sponsor: Genmab
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Platinum-Sensitive Ovarian Cancer Ovarian Cancer

Start date: 2026-08-01
Primary completion: 2029-12-01
Enrollment: 688

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.